Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models

References

• World Health Organization. Estimate of influenza deaths due to respiratory disease; [accessed 2020 Jan 2]. https://www.who.int/influenza/surveillance_monitoring/bod/en/.
   Google Scholar
• World Health Organization. Influenza (seasonal); [accessed 2020 Jan 2]. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal).
   Google Scholar
• Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices — United States, 2019–20 influenza season; [accessed 2020 Jan 3]. https://www.cdc.gov/mmwr/volumes/68/rr/rr6803a1.htm?s_cid=rr6803a1_w.
   Google Scholar
• Wright PF, Cherry JD, Foy HM, Glezen WP, Hall CB, McIntosh K, Monto AS, Parrott RH, Portnoy B, Taber LH, et al. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children – a multicentered evaluation of dosage and safety. Rev Infect Dis. 1983;5(4):758–64. PMID: 6353530. doi:10.1093/clinids/5.4.758.
   PubMedGoogle Scholar
• Beyer WEP, Palache AM, Osterhaus ADME. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines. Clin Drug Investig. 1998;15(1):1–12. PMID: 18370460. doi:10.2165/00044011-199815010-00001.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Vaccines against influenza WHO position paper – November 2012 [accessed 2020 Jan 3]. https://www.who.int/wer/2012/wer8747.pdf.
   Google Scholar
• Verma R, Khanna P, Chawla S. Influenza vaccine: an effective preventive vaccine for developing countries. Hum Vaccin. 2012;8(5):675–78. PMID: 22634439. doi:10.4161/hv.19516.
   PubMed Web of Science ®Google Scholar
• Kawaoka Y, Neumann G. Influenza virus surveillance, vaccine strain selection, and manufacture. Methods Mol Biol (Clifton, NJ). 2012;865:147–62. PMID: 22528158. doi:10.1007/978-1-61779-621-0_9.
   PubMedGoogle Scholar
• Van de witte SV, Nauta J, Giezeman-Smits KM, De Voogd JM. Trivalent inactivated subunit influenza vaccine Influvac®: 30-year experience of safety and immunogenicity. Trials Vaccinology. 2012;1:42–48. doi:10.1016/j.trivac.2012.10.001.
   Google Scholar
• Gian Vincenzo Z, Valentina F. Influvac, a trivalent inactivated subunit influenza vaccine. Expert Opin Biol Ther. 2011;11(1):89–98. PMID: 21110767. doi:10.1517/14712598.2011.541436.
   PubMed Web of Science ®Google Scholar
• Mckeage K. Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): a review of its use in the prevention of disease caused by influenza A and B. Drugs. 2013;73(14):1587–94. PMID: 24022123. doi:10.1007/s40265-013-0114-3.
   PubMed Web of Science ®Google Scholar
• Domachowske JB, Pankowculot H, Bautista M, Feng Y, Claeys C, Peeters M, Innis BL, Jain V. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3–17 years. J Infect Dis. 2013;207(12):1878–87. PMID: 23470848. doi:10.1093/infdis/jit091.
   PubMed Web of Science ®Google Scholar
• Beran J, Peeters M, Dewé W, Raupachová J, Hobzová L, Devaster JM. Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults. BMC Infect Dis. 2013;13(1):224–33. PMID: 23688546. doi:10.1186/1471-2334-13-224.
   PubMedGoogle Scholar
• Rodriguez Weber MA, Claeys C, Aranza DC, Feng Y, Innis BL, Jain VK, Peeters M. Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age. Pediatr Infect Dis J. 2014;33(12):1262–69. PMID: 25386965. doi:10.1097/INF.0000000000000463.
   PubMed Web of Science ®Google Scholar
• Bart S, Cannon K, Herrington D, Mills R, Forleo-Neto E, Lindert K, Abdul Mateen A. Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: a phase III, double-blind, multicenter, randomized, non-inferiority study. Hum Vaccin. 2016;12(9):2278–88. PMID: 27322354. doi:10.1080/21645515.2016.1182270.
   PubMed Web of Science ®Google Scholar
• Center for Drug Evaluation, NMPA. Technical guidelines of drug irritation, sensitization and hemolytic study; [accessed 2020 Dec 10]. http://www.cde.org.cn/zdyz.do?method=largePage&id=188.
   Google Scholar
• Palmer DF, Dowdle WR, Coleman MT, Schild GC. Advanced laboratory techniques for influenza diagnosis. Part 2. Hemagglutination inhibition test. Atlanta: US Department of Health Education and Welfare, PHS; 1975. p. 25–62.
   Google Scholar
• Forster R. Study designs for the nonclinical safety testing of new vaccine products ☆. J Pharmacol Toxicoll Methods. 2012;66(1):1–7. PMID: 22561062. doi:10.1016/j.vascn.2012.04.003.
   PubMed Web of Science ®Google Scholar
• Witte SVD, Nauta J, Montomoli E, Weckx J. A phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses. Vaccine. 2018;36(40):6030–38. PMID: 29709447. doi:10.1016/j.vaccine.2018.04.043.
   PubMed Web of Science ®Google Scholar
• Advisory Committee on Immunization Practices. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2019 [accessed 2019 Mar 6]. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html.
   Google Scholar
• Advisory Committee on Immunization Practices. Recommended adult immunization schedule for ages 19 years or older, United States, 2019 [accessed 2019 Mar 6]. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html.
   Google Scholar
• Hartvickson R, Cruz M, Ervin J, Brandon D, Forleo-Neto E, Dagnew AF, Chandra R, Lindert K, Mateen AA. Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial. Int J Infect Dis. 2015;41:65–72. PMID: 26585940. doi:10.1016/j.ijid.2015.11.004.
   PubMed Web of Science ®Google Scholar